AI News Deep Dive with Elephas
OpenAI and FDA Discussing AI Use for Faster Drug Approvals
11 May 2025
The world of medicine might be on the brink of a major change. OpenAI, the company that created ChatGPT, is now talking with the FDA about using artificial intelligence to speed up how new medicines get approved. These discussions could transform a process that currently takes over 10 years into something much faster. Imagine new treatments for diseases reaching patients months earlier because AI helped review the mountains of data that normally slow things down. While this technology brings hope, it also raises important questions about safety and reliability. In this article, we'll explore what's happening between OpenAI and the FDA, why drug approvals take so long now, how AI might change things, what concerns experts have, and what other companies are doing in this exciting space. Let's get into it.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
Dr. Erich G. Anderer, Chief of the Division of Neurosurgery and Surgical Director of Perioperative Services at NYU Langone Hospital–Brooklyn
09 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
Dr. Nolan Wessell, Assistant Professor and Well-being Co-Director, Department of Orthopedic Surgery, Division of Spine Surgery, University of Colorado School of Medicine
08 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
NPR News: 12-08-2025 2AM EST
08 Dec 2025
NPR News Now
NPR News: 12-08-2025 1AM EST
08 Dec 2025
NPR News Now